References
- Manola KN. Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview. Br J Haematol 2013; 163:24-39; PMID:23888868; http://dx.doi.org/10.1111/bjh.12484
- Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, Fry TJ, Orentas R, Sabatino M, Shah NN, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet 2015; 385:517-28; PMID:25319501; http://dx.doi.org/10.1016/S0140-6736(14)61403-3
- Park JH, Geyer MB, Brentjens RJ. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood 2016; 127(26):3312-20; PMID:27207800; http://dx.doi.org/10.1182/blood-2016-02-629063
- Somasundaram R, Ahsberg J, Okuyama K, Ungerback J, Lilljebjorn H, Fioretos T, Strid T, Sigvardsson M. Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states. Genes Dev 2016; 30:2486-99; PMID:27913602; http://dx.doi.org/10.1101/gad.285536.116
- Somasundaram R, Prasad MA, Ungerback J, Sigvardsson M. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia. Blood 2015; 126:144-52; PMID:25990863; http://dx.doi.org/10.1182/blood-2014-12-575688
- Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446:758-64; PMID:17344859; http://dx.doi.org/10.1038/nature05690
- Jacoby E, Nguyen SM, Fountaine TJ, Welp K, Gryder B, Qin H, Yang Y, Chien CD, Seif AE, Lei H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nature communications 2016; 7:12320; PMID:27460500; http://dx.doi.org/10.1038/ncomms12320